With the introduction of large-scale molecular profiling methods and high-throughput
sequencing technologies, the genomic features of most lymphoid neoplasms have been …

Molecular heterogeneity of diffuse large B-cell lymphoma (DLBCL) underlies the variable
outcomes achieved with immunochemotherapy. However, outcomes of gene expression …

While survival has improved for Burkitt lymphoma patients, potential differences in outcome
between pediatric and adult patients remain unclear. In both age groups, survival remains …

Summary Epstein–Barr virus (EBV)‐associated lymphomas cover a range of histological B‐
and T‐cell non‐Hodgkin and Hodgkin lymphoma subtypes. The role of EBV on B‐cell …

DDX3X is an RNA helicase with many functions in RNA metabolism such as mRNA
translation, alternative pre-mRNA splicing and mRNA stability, but also plays a role as a …

Loss-of-function of DDX3X is a leading cause of neurodevelopmental disorders (NDD) in
females. DDX3X is also a somatically mutated cancer driver gene proposed to have tumour …

Follicular lymphoma (FL) accounts for∼ 20% of all new lymphoma cases. Increases in
cytological grade are a feature of the clinical progression of this malignancy, and eventual …

Glucocorticoids have been used for decades to treat lymphomas without an established
mechanism of action. Using functional genomic, proteomic, and chemical screens, we …

Burkitt lymphoma (BL) is the most frequent B-cell lymphoma in pediatric patients. While most
patients are cured, a fraction of them are resistant to therapy. To investigate BL …

Burkitt lymphoma (BL) is an aggressive B‐cell lymphoma that occurs worldwide. A study of
BL in the US National Cancer Institute's Surveillance, Epidemiology and End Results …